AstraZeneca Straddles The Fence On Antibiotics; Is It About To Fall Off?
This article was originally published in The Pink Sheet Daily
Executive Summary
The big pharma denies reports it is disbanding antibiotics research, but says it is continuing to explore partnering opportunities for its non-core portfolio, including infectious disease.